Medical Devices & Tech

Endocare

201 Technology Drive
Irvine, CA 92618 USA
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Minimally Invasive Technology for Tissue and Tumor Ablation

Management Terrence A. Noonan, Director, Interim CEO & Interim President; Michael Rodriguez, CFO; Clint B. Davis, Senior Vice President, Legal Affairs, General Counsel and Secretary

Click here for Financial Data
Keywords: cancer, urological, surgery products, urology, prostate, urinary, bladder, erectile, advamed, cryotherapy, renal, pain, management, ablation, kidney, liver, lung, cryoablation, minimally invasive, metastases, palliative intervention

Comment


Updated: Aug. 22, 2013


Description

Endocare, Inc. is developing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing cryoablation (freezing) technologies for the treatment of ......view more

Products / Services

Cryoablation is a minimally invasive means of destroying cancerous and other target tissues in a non-toxic manner without the use of open surgery, radiation or dangerous chemicals. Cryocare CS is a fu......view more

Technology / Differentiation

One key element of the FDA-cleared Cryocare CS system is the AutoFreeze, a computer-controlled automated freezing mechanism that utilizes optimal power settings based upon target endpoint temperatures...view more

Market / Customers

Endocare's cryoablation technology platforms are marketed and sold by a direct-sales force to urologists and interventional radiologists. To date, the majority of sales have been to physicians for med......view more


Status

Endocare announced that it had agreed to merge with Israel-based Galil Medical in November 2008, a move that will result in a company with approximately $55 million in TTM revenues....view more

Analyst Coverage